Myalgia: An uncommon or underestimated side effect of mycopphenolate mophetil after transplantation? [10]

Nephrology Dialysis Transplantation

Volumn 19, Issue 7, 2004, Pages 1940-1942

  Piccoli, Giorgina P ^b   Rossetti, Maura ^b   Guarena, Cesare ^b   Consiglio, Valentina ^b   Mezza, Elizabetta ^b   Soragna, Giorgio ^b   Grassi, Giorgio ^a   Burdese, Manuel ^a   Gai, Massimo ^a   Marchetti, Piero ^b   Boggi, Ugo ^b   Segoloni, Giuseppe Paolo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DALFOPRISTIN PLUS QUINUPRISTIN; FELODIPINE; FLAVONE DERIVATIVE; ISOSORBIDE MONONITRATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEPRAZOLE; TACROLIMUS;

ADULT; ANEMIA; ANKLE EDEMA; ANXIETY; AUTOIMMUNE DISEASE; CASE REPORT; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG METABOLISM; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GOUT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; KIDNEY TRANSPLANTATION; LEG DISEASE; LETTER; LEUKOPENIA; MALE; MYALGIA; MYOPATHY; NAUSEA; NEUROPATHIC PAIN; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SIDE EFFECT; VOMITING;

EID: 3242721491     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh199     Document Type: Letter

References (6)

1. Greiner K, Varikkara M, Santiago C, Forrester JV. Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis. Ophthalmologe 2002; 99: 691-694
2. Mahe E, Meyer O, Descamps V, Picard-Danhan C, Crickx B. Early severe and transient arthralgia induced by mycophenolate mophetil in a patient with erythrodermal psoriasis. Ann Dermatol Vener 2002; 129: 1054-1055
3. Geilen CC, Arnold M, Orfanos CE. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients. Br J Dermatol 2001; 144: 583-586
4. Maes B, Oellerich M, Ceuppens JL et al. A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis. Nephrol Dial Transplant 2002; 17: 923-926
5. Carver PL, Whang E, Kauffman CA, Malani PN. Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy. Pharmacotherapy 2003; 23: 159-164
6. de Sevaux RG, Gregoor PJ, Hene RJ et al. A controlled trial comparino two doses of cyclosporine in conjunction with mycophenolate mofetil and corticosteroids. J Am Soc Nephrol 2001; 12: 1750-1757